About Eurasia Group and GZERO Media Eurasia Group is the worlds leading global research and advisory firm. We help clients understand, anticipate, and respond to instability and opportunities everywhere they do business. Together with GZERO Media—the
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)